A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the ...
AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug
The pharma is seeking full approval for its anticoagulation reversal drug Andexxa, which the FDA granted accelerated approval ...
Narcan is the only reversal drug distributed free of charge to organizations in state, but it's not the only reversal drug ...
Seven months ago, Cindy Jacquet came home after running errands with her daughter to find her son's car parked in front of ...
Protonitazene, a synthetic opioid three times stronger than fentanyl, was connected to an overdose in Stevenson Ranch. Dealer ...
Opioid agonists are the gold standard for the treatment of OUD but have not been able to solve the opioid crisis.
New litigation centered on increasing access to substance-use disorder treatment in jails and prisons is helping to reduce ...
Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...
The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...
Vertex expects to hear from the FDA by the end of January if suzetrigine will be approved ... albeit not more so than a ...
President-elect Donald Trump has selected Marty Makary, a Johns Hopkins surgeon who criticized the Biden administration’s Covid response, to lead the FDA. “FDA has lost the trust of Americans, and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback